title: Roundtable discussion: tadalafil study group.
authors: Division of Cardiovascular Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA. rkloner@goodsam.org
authors: Robert A
authors: RA
authors: Kloner
authors: Ralph G
authors: RG
authors: Brindis
authors: Melvin D
authors: MD
authors: Cheitlin
authors: Louis
authors: L
authors: Kuritzky
authors: Thomas A
authors: TA
authors: Miller
authors: Harin
authors: H
authors: Padma-Nathan
authors: Raymond C
authors: RC
authors: Rosen
mesh_terms: D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D002243:Carbolines / Q000494:pharmacology*; D002319:Cardiovascular System / Q000187:drug effects*; D004347:Drug Interactions; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D020030:Nitric Oxide Donors / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D000068581:Tadalafil
chemical_list: D002243:Carbolines; D020030:Nitric Oxide Donors; D010726:Phosphodiesterase Inhibitors; D000068581:Tadalafil; D015106:3',5'-Cyclic-GMP Phosphodiesterases